Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$866M |
| 2 |
Toronto Dominion Bank
TD
|
+$774M |
| 3 |
Bank of Montreal
BMO
|
+$469M |
| 4 |
Amgen
AMGN
|
+$402M |
| 5 |
TC Energy
TRP
|
+$282M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$558M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$361M |
| 3 |
Philip Morris
PM
|
+$347M |
| 4 |
Workday
WDAY
|
+$335M |
| 5 |
iShares MSCI All Country Asia ex Japan ETF
AAXJ
|
+$333M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.54% |
| 2 | Technology | 11.83% |
| 3 | Healthcare | 8.85% |
| 4 | Energy | 7.86% |
| 5 | Industrials | 7.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VIRS
3676
DELISTED
Pacer BioThreat Strategy ETF
VIRS
| $712K | ﹤0.01% |
26,750
+18,577
| +227% | +$529K |
|
3677
Sensient Technologies
SXT
$5.68B
| $711K | ﹤0.01% |
8,817
+4,310
| +96% | +$357K |
|
3678
Franklin Disruptive Commerce ETF
BUYZ
$5.53M
| $709K | ﹤0.01% |
33,911
+25,574
| +307% | +$629K |
|
|
HPS
3679
John Hancock Preferred Income Fund III
HPS
$457M
| $709K | ﹤0.01% |
44,977
-1,268
| -3% | -$21.1K |
|
3680
Agios Pharmaceuticals
AGIO
$2B
| $708K | ﹤0.01% |
31,926
+6,636
| +26% | +$150K |
|
3681
Invesco DB Base Metals Fund
DBB
$315M
| $708K | ﹤0.01% |
36,477
-47,294
| -56% | -$1.1M |
|
3682
Fidelity Total Bond ETF
FBND
$27.3B
| $708K | ﹤0.01% |
15,241
-360,274
| -96% | -$17.2M |
|
|
KF
3683
Korea Fund
KF
$267M
| $708K | ﹤0.01% |
29,077
-1,542
| -5% | -$43.3K |
|
|
BNFT
3684
DELISTED
Benefitfocus, Inc.
BNFT
| $708K | ﹤0.01% |
91,014
-5,403
| -6% | -$53.3K |
|
3685
Butterfly Network
BFLY
$2.35B
| $707K | ﹤0.01% |
230,505
-139,911
| -38% | -$483K |
|
3686
Regional Management Corp
RM
$309M
| $707K | ﹤0.01% |
18,907
-419
| -2% | -$18.5K |
|
|
BTEC
3687
DELISTED
Principal Exchange-Traded Funds Principal Healthcare Innovators ETF
BTEC
| $707K | ﹤0.01% |
21,948
-49,012
| -69% | -$1.64M |
|
|
BLE
3688
DELISTED
BlackRock Municipal Income Trust II
BLE
| $706K | ﹤0.01% |
63,884
+4,607
| +8% | +$52.3K |
|
|
TPIC
3689
DELISTED
TPI Composites
TPIC
| $706K | ﹤0.01% |
56,457
+36,516
| +183% | +$478K |
|
3690
Jackson Financial
JXN
$9.17B
| $705K | ﹤0.01% |
26,353
-22,674
| -46% | -$827K |
|
3691
iShares Core 10+ Year USD Bond ETF
ILTB
$592M
| $704K | ﹤0.01% |
12,651
-90
| -0.7% | -$5.18K |
|
3692
Innovator US Equity Buffer ETF March
BMAR
$256M
| $702K | ﹤0.01% |
22,701
+21,201
| +1,413% | +$694K |
|
3693
WesBanco
WSBC
$4.09B
| $700K | ﹤0.01% |
22,091
-7,075
| -24% | -$233K |
|
3694
Embecta
EMBC
$289M
| $699K | ﹤0.01% |
27,614
+15,080
| +120% | +$435K |
|
|
BSDE
3695
DELISTED
Invesco BulletShares 2024 USD Emerging Markets Debt ETF
BSDE
| $699K | ﹤0.01% |
28,901
-306
| -1% | -$7.53K |
|
3696
Gladstone Investment Corp
GAIN
$649M
| $697K | ﹤0.01% |
49,493
+9,948
| +25% | +$150K |
|
|
MYOV
3697
DELISTED
Myovant Sciences Ltd.
MYOV
| $695K | ﹤0.01% |
55,911
-62,576
| -53% | -$691K |
|
3698
Criteo S.A.
CRTO
$931M
| $694K | ﹤0.01% |
28,440
-2,707
| -9% | -$68.8K |
|
3699
UMB Financial
UMBF
$11.5B
| $694K | ﹤0.01% |
8,070
-756
| -9% | -$68.5K |
|
|
GENZ
3700
VanEck Digital Native Economy ETF
GENZ
$18M
| $692K | ﹤0.01% |
20,418
-23,080
| -53% | -$830K |
|
Similar funds
Royal Bank of Canada's Q2 2022 Portfolio in Review
As of Q2 2022, Royal Bank of Canada held 8,274 positions worth $340B, down 15% from $400B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Royal Bank of Canada's Q2 2022 filing shows 398 new, 2,517 increased, 3,856 reduced and 651 closed positions. Its largest new stake was Aspen Technology Inc: 92,306 shares worth $17M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $558M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 21% a quarter earlier, followed by Technology and Healthcare.
- Royal Bank of Canada's largest Q2 2022 buy was Aspen Technology Inc: 92,306 shares worth $17M.
- Royal Bank of Canada added most to iShares Core S&P 500 ETF in Q2 2022, an estimated $866M increase.
- Royal Bank of Canada's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $558M.
- Royal Bank of Canada fully exited Discovery, Inc. Series C Common Stock in Q2 2022, selling an estimated $45.7M.
- Royal Bank of Canada's ten largest holdings make up 20% of its $340B portfolio in Q2 2022.
- Royal Bank of Canada opened 398 new positions and closed 651 in Q2 2022.
- Royal Bank of Canada's portfolio value fell 15% quarter-over-quarter to $340B.
Based on Royal Bank of Canada's 13F filing for Q2 2022, filed 15 Aug 2022.